HC Wainwright & Co. Reiterates Buy on Palisade Bio, Maintains $7 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Palisade Bio (NASDAQ:PALI) with a Buy and maintains $7 price target.